Patrizia Matarazzo

Patrizia Matarazzo

Auto-generated profile, based on publicly available information

Patrizia Matarazzo

Department of Public Health and Pediatrics, University of Turin, Turin, Italy

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMartina Tetti
Martina Tetti
SILVIA MONTICONESILVIA MONTICONE
SILVIA MONTICONE
Jacopo BurrelloJacopo Burrello
Jacopo Burrello
PMPatrizia Matarazzo
Patrizia Matarazzo
FVFranco Veglio
Franco Veglio
PMPaolo Mulatero
Paolo Mulatero
Liddle syndrome is an inherited form of low-renin hypertension, transmitted with an autosomal dominant pattern. The molecular basis of Liddle syndrome resides in germline mutations of the SCNN1A, SCNN1B and SCNN1G genes, encoding the α, β, and γ-subunits of the epithelial Na+ channel (ENaC), respectively. To date, 31 different causative mutations have been reported in 72 families from four continents. The majority of the substitutions cause an increased expression of the channel at the distal nephron apical membrane, with subsequent enhanced renal sodium reabsorption. The most common clinical presentation of the disease is early onset hypertension, hypokalemia, metabolic alkalosis, suppressed plasma renin activity and low plasma aldosterone. Consequently, treatment of Liddle syndrome is based on the administration of ENaC blockers, amiloride and triamterene. Herein, we discuss the genetic basis, clinical presentation, diagnosis and treatment of Liddle syndrome. Finally, we report a new case in an Italian family, caused by a SCNN1B p.Pro618Leu substitution.

18 August 2020 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
GTGerdi Tuli
Gerdi Tuli
JMJessica Munarin
Jessica Munarin
DTDaniele Tessaris
Daniele Tessaris
SESilvia Einaudi
Silvia Einaudi
PMPatrizia Matarazzo
Patrizia Matarazzo
Luisa de SanctisLuisa de Sanctis
Luisa de Sanctis
In recent years, a more stable AVP surrogate, called copeptin, has been used as an adjuvant diagnostic tool for dysnatremia in adults and appears to be promising even in the pediatric age. The aim of this study is to present the distribution of plasma copeptin in a large pediatric cohort and to observe the influence of fluid consumption and obesity on its values. A cohort of 128 children and adolescents was divided into two groups on the basis of nocturnal deprivation (group A) or free access to oral fluids in the 6–8 h before blood collection (group B). At all distribution percentiles, copeptin levels were higher (p < 0.0001) in group A, as were plasma sodium levels and osmolality (p = 0.02 and p = 0.008, respectively). The influence of BMI on copeptin levels was investigated by dividing the cohort into nonobese (group C) and obese children and adolescents (group D). Copeptin levels were higher in group D (p = 0.04).Conclusion: The measurement of copeptin could represent a useful tool for the diagnostic pathway of dysnatremic conditions, but its interpretation should take into consideration the state of hydration. Furthermore, it could also be a promising marker for obesity and metabolic syndrome, although this hypothesis needs further studies to be confirmed. What is Known:• Copeptin use as a diagnostic tool in AVP-related disorders, such as diabetes insipidus or syndrome of inappropriate secretion of antidiuretic hormone, is well established in adults• In pediatric age, few studies are available, but the preliminary data, including our previous study, seems to be promising. What is New:• In this study, we represent the distribution of copeptin levels in a pediatric cohort and show the significant influence of fluid ingestion on its plasma levels.• Also BMI seems to be a significant variable on copeptin levels and may be used as an obesity marker in pediatric age

1 January 2021 in Case Reports in Endocrinology
Verified
Journal Article
Open access
PDF file
GTGerdi Tuli
Gerdi Tuli
JMJessica Munarin
Jessica Munarin
DTDaniele Tessaris
Daniele Tessaris
RBRaffaele Buganza
Raffaele Buganza
PMPatrizia Matarazzo
Patrizia Matarazzo
Luisa de SanctisLuisa de Sanctis
Luisa de Sanctis
Primary hyperparathyroidism (PHPT) is a rare disorder in children and adolescents. Typical biochemical features are hypercalcemia and hypophosphatemia, but the clinical features can be heterogeneous, and in some cases, symptoms are vague and nonspecific, leading to misdiagnosis or late diagnosis. Herein, we report two cases of PHPT in pediatric age with different presenting symptoms, pain in the foot, and progressive alteration of the gait in the first case and recurrent abdominal pain with emotional lability in the second. Biochemical and radiological assessment confirmed PHPT. Both cases were treated surgically as definitive treatment, but in the second case, previous medical treatment with cinacalcet, a calcimimetic agent, was required to reduce serum PTH and calcium levels. After surgery, despite conventional treatment with calcium and calcitriol, case 1 developed a hungry bone syndrome. The analysis of the MEN‐1 (Multiple Endocrine Neoplasia) gene was negative in both cases. A diagnosis of PHPT should be considered when children or adolescents present bone pain with radiological imaging of osteolytic lesion and biochemical feature of hypercalcemia associated with hypophosphatemia. In PHPT, the gold standard treatment is represented by surgery followed by strict postoperative endocrine monitoring to maintain adequate homeostasis of calcium and bone metabolism.

22 June 2021 in Children
Verified
Journal Article
Open access
PDF file
DTDaniele Tessaris
Daniele Tessaris
PMPatrizia Matarazzo
Patrizia Matarazzo
GTGerdi Tuli
Gerdi Tuli
ATAntonella Tuscano
Antonella Tuscano
IRIvana Rabbone
Ivana Rabbone
Luisa de SanctisLuisa de Sanctis
Luisa de Sanctis
Hypothalamic obesity (HO) is delineated by an inexorable weight gain in subjects with hypothalamic disorder (congenital or acquired). The aim of the present study was to evaluate the effect of a multidisciplinary approach on weight trend and metabolic outcome in children and adolescents with hypothalamic disease who were overweight or obese. Thirteen patients (aged 8.1–16.1 years) received a personalized diet, accelerometer-based activity monitoring, and psychological assessment. Height, weight, body mass index (BMI), and serum metabolic parameters were assessed at baseline (T0) and after six months (T1). Metformin was introduced at T1 in four subjects who were then re-evaluated after six months (T2). At T1, weight gain was significantly reduced compared with T0 (0.29 ± 0.79 kg/month vs. 0.84 ± 0.55 kg/month, p = 0.03), and weight standard deviation score (SDS) and BMI SDS did not change significantly, as serum metabolic parameters. The four subjects treated with metformin showed a reduction of weight SDS and BMI SDS at T2. In conclusion, patients treated with our multidisciplinary approach showed, after 6 months, favorable results characterized by decreased weight gain and stabilization of weight SDS and BMI SDS in a condition usually characterized by inexorable weight gain. However, further analysis, larger cohorts, and longer follow-up are needed to confirm these preliminary data.

1 January 1995 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PMP. Matarazzo
P. Matarazzo
RLRaushan Lala
Raushan Lala
LAL. Artesani
L. Artesani
PFP.G. Franceshini
P.G. Franceshini
CSC. De Sanctis
C. De Sanctis
We evaluated the possibility of anticipating spontaneous puberty in peripubertal Turner girls, in order to plan substitutive estrogen treatment. In the 24 patients studied, spontaneous puberty was seen in 4/11 girls with 45 XO karyotype, 5/5 with mosaicisms, 1 out of 2 with structural aberrations of the X chromosome and 0 out of 6 with Xq isochromosomes. When considering sonographic findings, the 6 girls with normal ovaries and 4/9 of those with intermediate ovarian appearance showed spontaneous puberty; the remaining 5 with intermediate ovaries and 9 with streak gonads did not undergo spontaneous puberty. Gonadotropin secretion was normal in girls with normal ovaries, moderately elevated in patients with intermediate ovarian appearance, and very high in those with streak gonads. The prognostic value of sonography and gonadotropins is particularly important in girls with intermediate ovaries. Therefore these evaluations should be performed at peripubertal age in patients with Turner's syndrome to elucidate the degree of ovarian insufficiency.

1 October 2019 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
VPViviana Valeria Palmieri
Viviana Valeria Palmieri
ALAntonella Lonero
Antonella Lonero
SBSarah Bocchini
Sarah Bocchini
GCGilda Cassano
Gilda Cassano
ACAlessio Convertino
Alessio Convertino
Maurizio DelvecchioMaurizio Delvecchio
Maurizio Delvecchio